Mictonorm Uno

Propiverine hydrochloride, the active ingredient in Mictonorm Uno, is an antimuscarinic presented as an oral tablet for oral use. It treats the symptoms of overactive bladder, including urgency, frequency, and urge urinary incontinence, in adult patients.

GNH USA supplies Mictonorm Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under strict Good Manufacturing Practice guidelines.

Propiverine hydrochloride is an antimuscarinic used to manage overactive bladder and related urinary symptoms. - Overactive bladder: reduces urgency, frequency and incontinence episodes. - Urinary urgency: improves control of sudden urges to void. - Urinary frequency: decreases the number of daytime voids. - Urge urinary incontinence: lessens involuntary leakage episodes.

Propiverine hydrochloride may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Dry mouth - Constipation - Blurred vision - Dizziness - Headache - Nausea

Serious or Rare Side Effects: - Urinary retention - Severe allergic reaction (anaphylaxis) - Tachycardia - Angle‑closure glaucoma - Hepatic dysfunction - Stevens‑Johnson syndrome

When prescribing propiverine hydrochloride, clinicians should consider several precautionary measures. - Renal impairment: assess renal function and adjust therapy if needed. - Hepatic impairment: use with caution and monitor liver enzymes. - Elderly patients: monitor for anticholinergic effects such as confusion. - History of urinary retention: avoid use as it may worsen retention. - Concomitant anticholinergic drugs: evaluate cumulative anticholinergic burden. - Store at room temperature: keep in original packaging, protect from moisture and light.

Propiverine hydrochloride can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may raise propiverine plasma concentrations. - Other antimuscarinic agents: additive anticholinergic effects increase risk of side effects. - Narrow‑angle glaucoma medication: may exacerbate intra‑ocular pressure.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of urinary retention. - Antihistamines: may increase dry mouth and constipation.